Study of ovarian cancer CTCs using Parsortix | Company Announcement
Investegate announcements from Study of ovarian cancer CTCs using Parsortix
Source: investegate.co.uk
📰 Framework Programme Grant News
Framework Programme Grant News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Framework Programme Grant. Real-time updates on events, politics, business and more.
ANGLE INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TR
The study investigated 123 metastatic ovarian cancer patients over two and a half years using the Parsortix system to assess 474 longitudinal patient samples Downstream qPCR molecular analysis of the Parsortix harvest for ESR1 and ERCC1 genes may be an early predictor of progression free survival and cancer pro...
United States Karen Miller University Of Vienna Framework Programme Grant International Journal Of Cancer American Cancer Society
Source: pharmiweb.com